- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Banco Bilbao Vizcaya Argentaria S.A. Reduces AbbVie Inc. Stake
Spanish bank cuts holdings in pharmaceutical giant by 5.9% in Q3 2025
Mar. 15, 2026 at 8:21am
Got story updates? Submit your updates here. ›
Banco Bilbao Vizcaya Argentaria S.A., a major Spanish financial institution, reduced its holdings in AbbVie Inc. (NYSE: ABBV) by 5.9% during the third quarter of 2025, according to a recent SEC filing. The bank now owns 356,703 shares of the pharmaceutical company's stock, valued at approximately $82.54 million.
Why it matters
AbbVie is a prominent global biopharmaceutical company, and changes in institutional ownership of its stock can provide insights into market sentiment and investment trends within the healthcare sector.
The details
Banco Bilbao Vizcaya Argentaria S.A. sold 22,214 shares of AbbVie during the third quarter, reducing its total position to 356,703 shares. The bank's holdings in AbbVie now account for approximately 0.6% of its overall portfolio.
- Banco Bilbao Vizcaya Argentaria S.A. filed its Q3 2025 Form 13F with the SEC on March 15, 2026.
The players
Banco Bilbao Vizcaya Argentaria S.A.
A major Spanish financial institution and one of the largest banks in Europe.
AbbVie Inc.
A global biopharmaceutical company that focuses on developing and commercializing therapies for complex and chronic medical conditions.
The takeaway
The reduction in Banco Bilbao Vizcaya Argentaria S.A.'s AbbVie holdings suggests a potential shift in the bank's investment strategy or portfolio allocation, though the reasons behind the move are not explicitly stated. Investors and analysts will likely monitor any further changes in institutional ownership of AbbVie stock to gauge broader market sentiment around the company.
